Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Greiner Website

John W. Greiner, Ph.D.

Selected Publications

1)  Fallon J, Tighe R, Kradjian G, Guzman W, Bernhardt A, Neuteboom B, Lan Y, Sabzevari H, Schlom J, Greiner JW.
The immunocytokine NHS-IL12 as a potential cancer therapeutic.
Oncotarget. 5: 1869-84, 2014.
2)  Takai S, Schlom J, Tucker J, Tsang KY, Greiner JW.
Inhibition of TGF-ß1 Signaling Promotes Central Memory T Cell Differentiation.
J. Immunol. 2013.
3)  Zeytin HE, Patel AC, Rogers CJ, Canter D, Hursting SD, Schlom J, Greiner JW.
Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
Cancer Res. 64: 3668-78, 2004.
4)  Greiner JW, Zeytin H, Anver MR, Schlom J.
Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity.
Cancer Res. 62: 6944-51, 2002.
5)  Kass E, Panicali DL, Mazzara G, Schlom J, Greiner JW.
Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
Cancer Res. 61: 206-14, 2001.
6)  Schlom J, Hodge JW, Palena C, Tsang KY, Jochems C, Greiner JW, Farsaci B, Madan RA, Heery CR, Gulley JL.
Therapeutic cancer vaccines.
Adv. Cancer Res. 121: 67-124, 2014.
7)  Zaharoff DA, Heffernan M, Fallo J, Greiner JW.
Sarmento B, das Neves J, eds.
Preclinical and clinical use of chitosan and derivatives for biopharmaceuticals from preclinical research to the bedside (Chapter 27). In: Chitosan-based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics.
New York: John Wiley & Sons; 2012. p. 525-541 [Book Chapter]
8)  Takai S, Sabzevari H, Farsaci B, Schlom J, Greiner JW.
Distinct effects of saracatinib on memory CD8+ T cell differentiation.
J. Immunol. 188: 4323-33, 2012.
9)  Heffernan MJ, Zaharoff DA, Fallon JK, Schlom J, Greiner JW.
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines.
Biomaterials. 32: 926-32, 2011.
10)  Bonmassar L, Fossile E, Scoppola A, Graziani G, Prete SP, Formica V, Cappelletti D, De Vecchis L, Cardillo A, Concolino F, D'Atri S, Balduzzi A, Torino F, Caporaso P, Greiner JW, Bonmassar E, Roselli M, Aquino A.
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
Anticancer Res. 30: 4721-30, 2010.
Click Here to View Expanded Bibliography.

This page was last updated on 6/20/2014.